Researchers developed a machine learning model, PAMmla, to predict properties of CRISPR-Cas9 enzymes, enhancing precision and ...

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions -- but there is always room for improvement. A new paper showcases the power of scalable protein ...

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions—but there is always room ...

Genome editing has progressed rapidly, showing promising outcomes for the treatment of genetic disorders, yet there remains ...

In a shining moment for Uganda and the African scientific community, Dr Matthias Magoola, founder of Dei Biopharma, has been ...

Researchers have developed a machine learning model that predicts Cas9 proteins that can be tailored with designer properties for therapeutic use.

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions—but there is always room for improvement. A new ...

Gain expert insights in this interview on achieving transfection success. Explore proven strategies to optimize your approach ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

ToolGen files patent infringement lawsuit against Vertex Pharma in UK for genome editing therapy CASGEVY: Seoul, South Korea Tuesday, April 22, 2025, 15:00 Hrs [IST] ToolGen, Inc.

Profluent has announced ProGen3, a new family of artificial intelligence (AI) models capable of designing complex proteins ...